+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Use of a commercial PCR kit for detecting Chlamydia trachomatis



Use of a commercial PCR kit for detecting Chlamydia trachomatis



Journal of Clinical Pathology 46(9): 822-825



Aims-To evaluate a commercial polymerase chain reaction (PCR) kit for the detection of Chlamydia trachomatis. Methods-Two hundred and fifty seven genital specimens, which had been submitted in 2SP medium for chlamydial isolation and subsequently stored at -70 degree C, were retrospectively examined by a commercial PCR kit which detects chlamydial plasmid DNA. Culture negative, PCR positive specimens were examined by immunofluorescence and an in-house major outer membrane protein (MOMP)-PCR. Results-All 49 specimens which were culture positive were also PCR positive. Another 14 specimens were also PCR positive. After resolution of these results by immunofluorescence and a PCR assay for MOMP the sensitivity for PCR was 98.4% and that of culture 79%. The specificities were 99.5% and 100%, respectively. Conclusions-This kit, which is highly sensitive and specific, is straightforward to use and has a built-in safeguard against cross contamination. The role of this test in the examination of routine genital specimens from patients with uncomplicated chlamydial infection is questionable due to its expense. It may have a place in the investigation of trachoma or infertility, however, where it has been shown that DNA can be detected when culture is unsuccessful.

(PDF emailed within 0-6 h: $19.90)

Accession: 009702943

Download citation: RISBibTeXText

PMID: 8227431

DOI: 10.1136/jcp.46.9.822


Related references

Evaluation of a new commercial microimmunofluorescence test for detection of antibodies to Chlamydia pneumoniae, Chlamydia trachomatis, and Chlamydia psittaci. European Journal of Clinical Microbiology & Infectious Diseases 16(9): 685-688, 1997

Performance of the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay in detecting Chlamydia trachomatis in endocervical and urine specimens from women and urethral and urine specimens from men attending sexually transmitted disease and family planning clinics. Journal of Clinical Microbiology 36(11): 3230-3233, 1998

Evaluation of a new chemiluminometric immunoassay, Magic Lite Chlamydia, for detecting Chlamydia trachomatis antigen from urogenital specimens. Sexually Transmitted Diseases 19(3): 161-164, 1992

Highly sensitive and novel point-of-care system, aQcare Chlamydia TRF kit for detecting Chlamydia trachomatis by using europium (Eu) (III) chelated nanoparticles. Annals of Laboratory Medicine 35(1): 50-56, 2016

Measurement of IgG antibodies to Chlamydia trachomatis by commercial enzyme immunoassays and immunofluorescence in sera from pregnant women and patients with infertility, pelvic inflammatory disease, ectopic pregnancy, and laboratory diagnosed Chlamydia psittaci/Chlamydia pneumoniae infection. Journal of Clinical Pathology 56(3): 225-229, 2003

Evaluation of the new COBAS TaqMan CT test v2.0 and impact on the proportion of new variant Chlamydia trachomatis by the introduction of diagnostics detecting new variant C trachomatis in Orebro county, Sweden. Sexually Transmitted Infections 85(3): 190-193, 2008

Detecting Chlamydia trachomatis. Nursing Standard 1987) 11(11): 29-29, 1996

Detecting chlamydia trachomatis infection in women. Acta Cytologica 45(5): 890-891, 2001

Sample adequacy in detecting Chlamydia trachomatis. International Journal of Gynecology & Obstetrics 51(3): 225-228, 1995

Comparison of methods for detecting Chlamydia trachomatis. Journal of Clinical Pathology 39(2): 232-233, 1986

Clinical trial performance of the VIDAS PROBE Chlamydia trachomatis Test for detecting C trachomatis in endocervical and urine specimens from women and urethral and urine specimens from men. Abstracts of the General Meeting of the American Society for Microbiology 103: C-036, 2003

Non-invasive sampling method for detecting Chlamydia trachomatis. Lancet 1(8629): 96-97, 1989

Evaluation of two ELISA's for detecting Chlamydia trachomatis from endocervical swabs. Diagnostic Microbiology and Infectious Disease 15(7): 579-586, 1992

Monoclonal antibody based ELISA for detecting Chlamydia trachomatis. Lancet 1(8423): 279-279, 1985